Myocardial effects of early therapy with perindopril during experimental cardiomyopathy

The American Journal of Cardiology

Volumn 71, Issue 17, 1993, Pages

  Chemla, Denis ^a   Scalbert, Elizabeth ^b   Desché, Pierre ^b   Pourny, Jean Claude ^a   Lambert, Francine ^a   Lecarpentier, Yves ^c  

^a LABORATOIRE D OPTIQUE APPLIQUÉE   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

^c Societé de Physiologie UER Kremlin Bicêtre ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART PAPILLARY MUSCLE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYRIAN HAMSTER;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; CARDIOMYOPATHY, CONGESTIVE; HAMSTERS; INDOLES; MESOCRICETUS; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES; PERINDOPRIL; RANDOM ALLOCATION; STIMULATION, CHEMICAL;

EID: 0027324659     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(93)90952-9     Document Type: Article

References (44)

1. ACE inhibitors—a cornerstone of the treatment of heart failure
2. Pathophysiology of heart failure
3. The cardiac renin-angiotensin system An appraisal of present experimental and clinical evidence
4. Experimental models of heart failure
5. Abnormal intracellular calcium handling in acute and chronic heart failure role of systolic and diastolic dysfunction
6. The heart in muscular dystrophy with special reference to involvement of the cardiovascular system in the hereditary myopathy of the hamster
7. Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural features
8. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I: Progression of heart and skeletal muscle lesions in the UM-X7-1 line
9. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure
10. Calcium transport of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (Bio 53.58 and 14.6): evidence for a quantitative defect in dilated myopathie hearts not evident in hypertrophic hearts
11. Regulatory proteins in hamster cardiomyopathy
12. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis
13. Disturbed myocardial calcium metabolism: a possible pathogenic factor in the hereditary cardiomyopathy of the Syrian hamster
14. Mitochondrial calcium overload in cardiomyopathic hamsters
15. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster
16. Comparative effects of calcium antagonists and of inotropic agents on the development of hereditary cardiomyopathy in the hamster
17. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates
18. Effects of perindopril on myocardial inotropy, lusitropy and economy, and on diaphragmatic contractility in the cardiomyopathic Syrian hamster
19. Inhibition of angiotensin I-converting enzyme with S-9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects
20. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction
21. Myocardial adaptation to stress from the viewpoint of evolution and development
22. Energetic aspects of muscle contraction
23. Effects of ketamine on the cardiac papillary muscle of normal hamsters and those with cardiomyopathy
24. Myocardial contractility, lusitropy and calcium responsiveness in young (50 days) and hypertrophied (180 days) cardiomyopathic hamsters
25. Nature of load dependence of relaxation in cardiac muscle
26. Relationship between inotropy and relaxation in rat myocardium
27. The heat of shortening and the dynamic constants of muscle
28. Coordinated changes in contractility, energetics and isomyosins after aortic stenosis
29. Proposed mechanism of force generation in striated muscle
30. A simple radioassay for angiotensin converting enzyme
31. Early therapy with perindopril improves diaphragmatic contractility in the cardiomyopathic Syrian hamster
32. The dystrophic hamster: an animal model of alveolar hypoventilation
33. Relations between myocardial contractility, myosin phenotype and plasma angiotensin converting enzyme activity in the cardiomyopathic hamster
34. Mechanical properties of papillary muscle in cardiac failure: importance of pathogenesis and of ventricle origin
35. Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril
36. Effects of an angiotensin converting enzyme inhibitor cilazapril on chronic heart failure in the cardiomyopathic hamster (Abstr)
37. Inotropic effects of angiotensm II on human cardiac muscle in vitro
38. Angiotensin II-forming pathways in normal and failing human heart
39. Cellular mechanisms in congestive heart failure
40. Effect on the myocardial energy metabolism of angiotensinconverting-enzyme inhibition in chronic heart failure
41. Respiratory muscle fatigue during cardiogenic shock
42. Respiratory muscle strength in congestive heart failure
43. Intrinsic alterations in mechanics and energetics of rabbits diaphragm during chronic congestive heart failure
44. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure